Sally Lam, Pharm.D., MBA
Head of Marketing, Customer Engagement at Reata Pharmaceuticals, Inc.- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
-
English Full professional proficiency
-
Chinese Native or bilingual proficiency
Topline Score
Bio
Leonard D. Lane
I highly recommend Sally for a leadership position in the Marketing/customer engagement area. Sally has Extensive omnichannel, brand, marketing operations, and thought-leader experience in pharma-biotech industries including extensive launch experience with new and existing markets. During her career she has proven to be an Innovative and strategic leader with highly effective communication and relationship-building skills including strong collaboration and influence capabilities which she has leveraged across all levels of an organization. Perhaps most importantly in our networked world Sally has a proven ability to leverage talent to solve problems through her generative listening capability coupled with a laser-sharp customer focus. Sally is a value- added asset to any organization she works for
Kathleen Kobashi
Sally Lam is a gem. She is one of those rare individuals who embodies the "full package:" personable, innovative, dependable, and consistent. She is a motivational leader and a strategic problem-solver who builds and inspires topnotch teams and creates meaningful long-term relationships with physicians to benefit our patients. As outstanding as Sally is at her job, she is always seeking to learn and grow, and with her comprehensive understanding of the landscape, she brings an invaluable perspective to the table.
Leonard D. Lane
I highly recommend Sally for a leadership position in the Marketing/customer engagement area. Sally has Extensive omnichannel, brand, marketing operations, and thought-leader experience in pharma-biotech industries including extensive launch experience with new and existing markets. During her career she has proven to be an Innovative and strategic leader with highly effective communication and relationship-building skills including strong collaboration and influence capabilities which she has leveraged across all levels of an organization. Perhaps most importantly in our networked world Sally has a proven ability to leverage talent to solve problems through her generative listening capability coupled with a laser-sharp customer focus. Sally is a value- added asset to any organization she works for
Kathleen Kobashi
Sally Lam is a gem. She is one of those rare individuals who embodies the "full package:" personable, innovative, dependable, and consistent. She is a motivational leader and a strategic problem-solver who builds and inspires topnotch teams and creates meaningful long-term relationships with physicians to benefit our patients. As outstanding as Sally is at her job, she is always seeking to learn and grow, and with her comprehensive understanding of the landscape, she brings an invaluable perspective to the table.
Leonard D. Lane
I highly recommend Sally for a leadership position in the Marketing/customer engagement area. Sally has Extensive omnichannel, brand, marketing operations, and thought-leader experience in pharma-biotech industries including extensive launch experience with new and existing markets. During her career she has proven to be an Innovative and strategic leader with highly effective communication and relationship-building skills including strong collaboration and influence capabilities which she has leveraged across all levels of an organization. Perhaps most importantly in our networked world Sally has a proven ability to leverage talent to solve problems through her generative listening capability coupled with a laser-sharp customer focus. Sally is a value- added asset to any organization she works for
Kathleen Kobashi
Sally Lam is a gem. She is one of those rare individuals who embodies the "full package:" personable, innovative, dependable, and consistent. She is a motivational leader and a strategic problem-solver who builds and inspires topnotch teams and creates meaningful long-term relationships with physicians to benefit our patients. As outstanding as Sally is at her job, she is always seeking to learn and grow, and with her comprehensive understanding of the landscape, she brings an invaluable perspective to the table.
Leonard D. Lane
I highly recommend Sally for a leadership position in the Marketing/customer engagement area. Sally has Extensive omnichannel, brand, marketing operations, and thought-leader experience in pharma-biotech industries including extensive launch experience with new and existing markets. During her career she has proven to be an Innovative and strategic leader with highly effective communication and relationship-building skills including strong collaboration and influence capabilities which she has leveraged across all levels of an organization. Perhaps most importantly in our networked world Sally has a proven ability to leverage talent to solve problems through her generative listening capability coupled with a laser-sharp customer focus. Sally is a value- added asset to any organization she works for
Kathleen Kobashi
Sally Lam is a gem. She is one of those rare individuals who embodies the "full package:" personable, innovative, dependable, and consistent. She is a motivational leader and a strategic problem-solver who builds and inspires topnotch teams and creates meaningful long-term relationships with physicians to benefit our patients. As outstanding as Sally is at her job, she is always seeking to learn and grow, and with her comprehensive understanding of the landscape, she brings an invaluable perspective to the table.
Credentials
-
Doctor of Pharmacy
University of the Pacific -
Executive MBA
University of California, Irvine - The Paul Merage School of Business -
Residency in Pediatric Clinical Pharmacy
University of California, Davis
Experience
-
Reata Pharmaceuticals, Inc.
-
United States
-
Pharmaceutical Manufacturing
-
200 - 300 Employee
-
Head of Marketing, Customer Engagement
-
Aug 2019 - Present
- At REATA, I led the Customer Engagment team through the successful launch of SKYCLARYS in Friedreich’s ataxia (FA), a rare neurological disease, which resulted in a landmark $7.3B acquisition by Biogen (Sept 2023). - In a resource-constrained emerging company and tenuous FDA environment with multiple set-backs, I built a team that fostered pre- and post-launch successes through seamless team integration (sales, med affairs, payer, market access, IT, Finance, Regulatory, Compliance… Show more - At REATA, I led the Customer Engagment team through the successful launch of SKYCLARYS in Friedreich’s ataxia (FA), a rare neurological disease, which resulted in a landmark $7.3B acquisition by Biogen (Sept 2023). - In a resource-constrained emerging company and tenuous FDA environment with multiple set-backs, I built a team that fostered pre- and post-launch successes through seamless team integration (sales, med affairs, payer, market access, IT, Finance, Regulatory, Compliance, Legal, Global commercial, and C-suite) across the organization. - My team was responsible for creating REATA’s first best-in-class Omnichannel strategy, Payer strategy, Ad board plan, Speaker program plan and Marketing operations plan. - The design of a cohesive KOL-Patient-Payer-Advocacy strategy built from ground-up led to the strategic partnerships that significantly led to the immediate and steep adoption of SKYCLARYS in the FA community. - Internally, I Ied cross functional team collaborations to drive alignment across key marketing initiatives (Physician, Patient, Payer audiences) related to marketing strategy, marketing campaigns, product branding and positioning, and messaging -The strategic priming and creation of a market with strong unmet needs led to a remarkable launch of the first drug for Friedreich ataxia Show less - At REATA, I led the Customer Engagment team through the successful launch of SKYCLARYS in Friedreich’s ataxia (FA), a rare neurological disease, which resulted in a landmark $7.3B acquisition by Biogen (Sept 2023). - In a resource-constrained emerging company and tenuous FDA environment with multiple set-backs, I built a team that fostered pre- and post-launch successes through seamless team integration (sales, med affairs, payer, market access, IT, Finance, Regulatory, Compliance… Show more - At REATA, I led the Customer Engagment team through the successful launch of SKYCLARYS in Friedreich’s ataxia (FA), a rare neurological disease, which resulted in a landmark $7.3B acquisition by Biogen (Sept 2023). - In a resource-constrained emerging company and tenuous FDA environment with multiple set-backs, I built a team that fostered pre- and post-launch successes through seamless team integration (sales, med affairs, payer, market access, IT, Finance, Regulatory, Compliance, Legal, Global commercial, and C-suite) across the organization. - My team was responsible for creating REATA’s first best-in-class Omnichannel strategy, Payer strategy, Ad board plan, Speaker program plan and Marketing operations plan. - The design of a cohesive KOL-Patient-Payer-Advocacy strategy built from ground-up led to the strategic partnerships that significantly led to the immediate and steep adoption of SKYCLARYS in the FA community. - Internally, I Ied cross functional team collaborations to drive alignment across key marketing initiatives (Physician, Patient, Payer audiences) related to marketing strategy, marketing campaigns, product branding and positioning, and messaging -The strategic priming and creation of a market with strong unmet needs led to a remarkable launch of the first drug for Friedreich ataxia Show less
-
-
-
Allergan
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Sr. Director, Marketing Communications, BOTOX Urology/Neurology
-
Jan 2011 - May 2019
- At ALLERGAN, I spearheaded the successful launch of 3 groundbreaking BOTOX indications in urology and neurology that established Allergan’s undeniable leadership position in these areas. - This resulted in exceeding annual sales goals year after year to establish a dominant market position. - I led a team that built robust KOL engagement plans, innovative physician training plans, Medical conference plans, and Ad boards plans. - The Strategic Communication department that I… Show more - At ALLERGAN, I spearheaded the successful launch of 3 groundbreaking BOTOX indications in urology and neurology that established Allergan’s undeniable leadership position in these areas. - This resulted in exceeding annual sales goals year after year to establish a dominant market position. - I led a team that built robust KOL engagement plans, innovative physician training plans, Medical conference plans, and Ad boards plans. - The Strategic Communication department that I built in BOTOX Urology and Neurology - this model was replicated across Allergan franchises and continues to live on today. Show less - At ALLERGAN, I spearheaded the successful launch of 3 groundbreaking BOTOX indications in urology and neurology that established Allergan’s undeniable leadership position in these areas. - This resulted in exceeding annual sales goals year after year to establish a dominant market position. - I led a team that built robust KOL engagement plans, innovative physician training plans, Medical conference plans, and Ad boards plans. - The Strategic Communication department that I… Show more - At ALLERGAN, I spearheaded the successful launch of 3 groundbreaking BOTOX indications in urology and neurology that established Allergan’s undeniable leadership position in these areas. - This resulted in exceeding annual sales goals year after year to establish a dominant market position. - I led a team that built robust KOL engagement plans, innovative physician training plans, Medical conference plans, and Ad boards plans. - The Strategic Communication department that I built in BOTOX Urology and Neurology - this model was replicated across Allergan franchises and continues to live on today. Show less
-
-
-
Limerick BioPharma
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
Director, Strategic Marketing
-
Dec 2007 - Oct 2010
At LIMERICK, I assessed and identified early-stage preclinical molecules for advancement, contributing to the successful progression of assets into Phase 1b trials in kidney transplant. At LIMERICK, I assessed and identified early-stage preclinical molecules for advancement, contributing to the successful progression of assets into Phase 1b trials in kidney transplant.
-
-
-
UCB
-
Belgium
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Associate Director, Medical Science Liaison
-
Jun 2004 - Dec 2007
At UCB, I led a team of 8 Medical Science Liaisons (MSLs) through 3 product launches in epilepsy (Keppra) and Parkinson’s disease (Neupro). At UCB, I led a team of 8 Medical Science Liaisons (MSLs) through 3 product launches in epilepsy (Keppra) and Parkinson’s disease (Neupro).
-
-
-
InterMune
-
Biotechnology
-
1 - 100 Employee
-
Director, Medical Information
-
Jul 2001 - Jun 2004
- At INTERMUNE, I established the company's first in-house Medical Information department, resulting in significant annual cost savings and a substantial increase in customer call volume. - I hired, managed, and led a team of Medical Information specialists, including Pharm.D.'s. - At INTERMUNE, I established the company's first in-house Medical Information department, resulting in significant annual cost savings and a substantial increase in customer call volume. - I hired, managed, and led a team of Medical Information specialists, including Pharm.D.'s.
-
-
-
MedicaLogic (Now Medscape)
-
San Francisco, California
-
Sr Manager, Business Development
-
Jun 1999 - Apr 2001
- As a leader at MEDICALOGIC, I played a key role in penetrating Fortune 500 pharmaceutical accounts. - I led efforts on the BD team to evaluate and negotiate strategic partnership deals to expand the early adoption of electronic health records (EHR). - The goal was to improve access and transfer of patient chart information to improve patient care. - As a leader at MEDICALOGIC, I played a key role in penetrating Fortune 500 pharmaceutical accounts. - I led efforts on the BD team to evaluate and negotiate strategic partnership deals to expand the early adoption of electronic health records (EHR). - The goal was to improve access and transfer of patient chart information to improve patient care.
-
-
Education
-
2015 - 2017
University of California, Irvine
Executive MBA, Business Administration and Management -
1989 - 1992
University of the Pacific
Doctor of Pharmacy -
Lowell High School
High School diploma, Science
Community
